Chidi N Obasi1, Roger L Brown, Bruce P Barrett. 1. Department of Family Medicine, University of Wisconsin-Madison, 1100 Delaplaine Ct., Madison, WI, 53715, USA, cobasi@wisc.edu.
Abstract
PURPOSE: To develop a shorter version of the Wisconsin Upper Respiratory Symptom Survey (WURSS-21), a self-report questionnaire for evaluating daily symptoms and functional impairments during acute respiratory illness (ARI). METHODS: WURSS-21 data were retrieved from 4 studies (n = 1167) spanning the years 2002-2010. Similar methodologies were employed among these studies. Degree of missingness, ceiling/floor effects, and exploratory (EFA) and confirmatory (CFA) factor analyses were investigated and used to guide item retention. Stability of the reduced WURSS was evaluated across the first 3 days of ARI. RESULTS: Degree of missingness was <1 % and appeared to be completely at random. Seven WURSS items with >30 % of ratings of zero (floor effects) were eliminated. Cross-loading items (head congestion, sleep well and breathe easily) were excluded following EFA on subset-1. Subsequent CFA using subset-2 showed satisfactory indices of fit. The reduced WURSS-11 instrument demonstrated 3 dimensions of 3 items each and was stable across 3 days of illness. The indicated dimensions (items) include nasal (runny nose, plugged nose, sneezing), throat (cough, sore throat, scratchy throat), and quality of life (feeling tired, think clearly, accomplish daily activities). CONCLUSION: The WURSS-11 has similar dimensional structure as the WURSS-21. This shorter version may reduce the time and burden required for completing the survey.
PURPOSE: To develop a shorter version of the Wisconsin Upper Respiratory Symptom Survey (WURSS-21), a self-report questionnaire for evaluating daily symptoms and functional impairments during acute respiratory illness (ARI). METHODS: WURSS-21 data were retrieved from 4 studies (n = 1167) spanning the years 2002-2010. Similar methodologies were employed among these studies. Degree of missingness, ceiling/floor effects, and exploratory (EFA) and confirmatory (CFA) factor analyses were investigated and used to guide item retention. Stability of the reduced WURSS was evaluated across the first 3 days of ARI. RESULTS: Degree of missingness was <1 % and appeared to be completely at random. Seven WURSS items with >30 % of ratings of zero (floor effects) were eliminated. Cross-loading items (head congestion, sleep well and breathe easily) were excluded following EFA on subset-1. Subsequent CFA using subset-2 showed satisfactory indices of fit. The reduced WURSS-11 instrument demonstrated 3 dimensions of 3 items each and was stable across 3 days of illness. The indicated dimensions (items) include nasal (runny nose, plugged nose, sneezing), throat (cough, sore throat, scratchy throat), and quality of life (feeling tired, think clearly, accomplish daily activities). CONCLUSION: The WURSS-11 has similar dimensional structure as the WURSS-21. This shorter version may reduce the time and burden required for completing the survey.
Authors: Bruce Barrett; Kristin Locken; Rob Maberry; Jason Schwamman; Roger Brown; Jim Bobula; Ellyn A Stauffacher Journal: J Fam Pract Date: 2002-03 Impact factor: 0.493
Authors: Bruce Barrett; Mary S Hayney; Daniel Muller; David Rakel; Ann Ward; Chidi N Obasi; Roger Brown; Zhengjun Zhang; Aleksandra Zgierska; James Gern; Rebecca West; Tola Ewers; Shari Barlow; Michele Gassman; Christopher L Coe Journal: Ann Fam Med Date: 2012 Jul-Aug Impact factor: 5.166
Authors: Bruce P Barrett; Roger L Brown; Kristin Locken; Rob Maberry; James A Bobula; Donn D'Alessio Journal: Ann Intern Med Date: 2002-12-17 Impact factor: 25.391
Authors: Bruce Barrett; Roger Brown; Dave Rakel; David Rabago; Lucille Marchand; Jo Scheder; Marlon Mundt; Gay Thomas; Shari Barlow Journal: Ann Fam Med Date: 2011 Jul-Aug Impact factor: 5.166
Authors: Bruce Barrett; Dave Rakel; Betty Chewning; Lucille Marchand; David Rabago; Roger Brown; Jo Scheder; Raandi Schmidt; James E Gern; Kerry Bone; Gay Thomas; Shari Barlow; James Bobula Journal: Explore (NY) Date: 2007 Nov-Dec Impact factor: 1.775
Authors: Bruce Barrett; Roger Brown; Marlon Mundt; Nasia Safdar; Leota Dye; Rob Maberry; Jennifer Alt Journal: J Clin Epidemiol Date: 2005-06 Impact factor: 6.437
Authors: Bruce Barrett; Roger L Brown; Marlon P Mundt; Gay R Thomas; Shari K Barlow; Alex D Highstrom; Mozhdeh Bahrainian Journal: Health Qual Life Outcomes Date: 2009-08-12 Impact factor: 3.186
Authors: Mary S Hayney; Kelsey M Henriquez; Jodi H Barnet; Tola Ewers; Heather M Champion; Sean Flannery; Bruce Barrett Journal: J Clin Virol Date: 2017-03-16 Impact factor: 3.168
Authors: Rob Arbuckle; Patricia Halstead; Chris Marshall; Brenda Zimmerman; Kate Bolton; Antoine Regnault; Cathy Gelotte Journal: Patient Date: 2020-11-11 Impact factor: 3.883
Authors: Sandy Lewis; Carla DeMuro; Stan L Block; Shelly Senders; Paul Wisman; Seth Toback; Jason W Chien; Valerie Williams Journal: J Patient Rep Outcomes Date: 2018-02-21
Authors: Hyun Chul Jung; Myong-Won Seo; Sukho Lee; Sung Woo Kim; Jong Kook Song Journal: Int J Environ Res Public Health Date: 2018-09-14 Impact factor: 3.390